HVIVO PLC Logo

HVIVO PLC

A contract research organization specializing in human challenge trials for biopharma.

HVO | IL

Overview

Corporate Details

ISIN(s):
GB00B9275X97
LEI:
213800VT5KBM7JLIV118
Country:
United Kingdom
Address:
QUEEN MARY BIOENTERPRISES INNOVATION CENTRE, E1 2AX LONDON

Description

hVIVO plc is a full-service contract research organization (CRO) and a leading specialist in human challenge trials. The company provides end-to-end clinical development solutions for a global biopharma client base, focusing on infectious and respiratory diseases. Its services span from preclinical consultancy to Phase III clinical trials, including first-in-human studies, biometry, and consulting. hVIVO operates a state-of-the-art quarantine facility in London and provides advanced laboratory services under its hLAB brand. Through subsidiaries such as CRS and Venn Life Sciences, it offers early-phase clinical trial expertise and patient recruitment across multiple clinical sites. The company's integrated approach is designed to accelerate the development of vaccines and therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-18 08:20
Appointment of Non-Executive Director
English 34.7 KB
2025-12-15 16:00
CEO & CFO Share Purchase
English 43.5 KB
2025-11-27 08:30
MSD to acquire Cidara
English 20.0 KB
2025-11-20 08:20
>£5 million CRS contracts signed
English 20.5 KB
2025-11-11 08:25
Positive data from novel human challenge models
English 23.6 KB
2025-11-06 18:15
Holding(s) in Company
English 22.7 KB
2025-11-03 08:30
Presentation at Jefferies Healthcare Conference
English 17.0 KB
2025-09-23 08:00
Interim results
English 206.9 KB
2025-09-04 08:00
Notice of Results
English 18.1 KB
2025-07-29 08:00
Proposed appointment of Chair
English 16.3 KB
2025-07-22 08:00
H1 Trading update
English 26.7 KB
2025-07-18 08:00
Directorate Change
English 16.4 KB
2025-07-09 08:00
Notice of Trading Update
English 17.4 KB
2025-07-01 17:04
Holding(s) in Company
English 24.3 KB
2025-06-30 08:00
Positive results from client Phase 2b field study
English 22.0 KB

Automate Your Workflow. Get a real-time feed of all HVIVO PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HVIVO PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HVIVO PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

PULSE BIOSCIENCES, INC. Logo
A bioelectric medicine company developing non-thermal nsPFA technology for tissue ablation.
United States of America
PLSE
Q32 Bio Inc. Logo
A clinical-stage biotech developing therapies for autoimmune and inflammatory diseases.
United States of America
QTTB
QinetiQ Group PLC Logo
A science and engineering company providing technology for defence and security sectors.
United Kingdom
QQ
Qualigen Therapeutics, Inc. Logo
Clinical-stage biotech developing novel cancer treatments for rare and unmet needs.
United States of America
QLGN
Quanterix Corp Logo
Digitizes biomarker analysis with an ultra-sensitive digital immunoassay platform.
United States of America
QTRX
Develops quantum-secure fingerprints for product authentication and anti-counterfeiting.
United Kingdom
QUBE
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Logo
An R&D company using AI and quantum computing to enhance Bitcoin mining efficiency.
United Kingdom
QBT
QUIA PHARMA AB Logo
Develops medicines using a proprietary drug delivery platform to improve efficacy.
Sweden
QUIA
Qurient Co., Ltd. Logo
Clinical-stage biopharma developing drugs for oncology, cGvHD, and tuberculosis.
South Korea
115180
Radiopharm Theranostics Ltd Logo
Clinical-stage company developing radiopharmaceuticals for cancer diagnosis and treatment.
United States of America
RADX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.